Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

The case of visceral fat: argument for the defense
Samuel Klein
Samuel Klein
Published June 1, 2004
Citation Information: J Clin Invest. 2004;113(11):1530-1532. https://doi.org/10.1172/JCI22028.
View: Text | PDF
Commentary Article has an altmetric score of 26

The case of visceral fat: argument for the defense

  • Text
  • PDF
Abstract

Increased plasma fatty acid concentrations may be responsible for many of the metabolic abnormalities associated with abdominal obesity. Excessive visceral fat is associated with insulin resistance and other metabolic risk factors for coronary heart disease. A study reported in this issue of the JCI evaluates the relative contribution of fatty acids released during lipolysis of visceral adipose tissue triglycerides to portal and systemic fatty acid flux in human subjects.

Authors

Samuel Klein

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Total
Citations: 1 4 2 4 5 1 1 6 3 6 1 10 3 4 3 5 3 2 2 1 67
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2014 (10)

Title and authors Publication Year
Abdominal obesity: causal factor or simply a symptom of obesity-related health risk
S Oh, K Tanaka, JW Noh, R So, T Tsujimoto, H Sasai, M Kim, J Shoda
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2014
Sex and sex steroids: impact on the kinetics of fatty acids underlying body shape
S Santosa, MD Jensen
Hormone Molecular Biology and Clinical Investigation 2014
Metabolic fate of fructose in human adipocytes: a targeted 13C tracer fate association study
V Varma, LG Boros, GT Nolen, CW Chang, M Wabitsch, RD Beger, J Kaput
Metabolomics 2014
Relationship of muscle sympathetic nerve activity to insulin sensitivity
TB Curry, CN Hines, JN Barnes, M Somaraju, R Basu, JM Miles, MJ Joyner, N Charkoudian
Clinical Autonomic Research 2014
Clinico-Biochemical Correlation Between Psoriasis and Insulin Resistance
S Dhara, A Dasgupta, JK Rout, U Banerjee, S Dasgupta, A Ghosh
Indian Journal of Clinical Biochemistry 2014
Obesity attenuates gender differences in cardiovascular mortality
Song X, Tabák AG, Zethelius B, Yudkin JS, Söderberg S, Laatikainen T, Stehouwer CD, Dankner R, Jousilahti P, Onat A, Nilsson PM, Satman I, Vaccaro O, Tuomilehto J, Qiao Q
Cardiovascular Diabetology 2014
Quantification of Abdominal Fat Depots in Rats and Mice during Obesity and Weight Loss Interventions
KN BP, Gopalan V, Lee SS, Velan SS
PloS one 2014
Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunction
Bays H
Current opinion in endocrinology, diabetes, and obesity 2014
Sex-related differences in the effects of high-fat diets on DHEA-treated rats.
Cecconello AL, Trapp M, Hoefel AL, Marques CV, Arbo BD, Osterkamp G, Kucharski LC, Ribeiro MF
Endocrine 2014
Impact of body composition on estimated glomerular filtration rate in relatively healthy adults in Taiwan.
Tsai YW, Ho CI, Chen JY, Chang KC, Weng YM, Chen SY, Li WC
European Journal of Clinical Nutrition 2014

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 2 news outlets
Referenced in 1 patents
On 3 Facebook pages
On 2 videos
Referenced in 1 clinical guideline sources
37 readers on Mendeley
See more details